Free Trial

Autonomix Medical (AMIX) Competitors

Autonomix Medical logo
$1.20 -0.04 (-3.23%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.20 0.00 (0.00%)
As of 08/8/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AMIX vs. BDMD, XAIR, MHUA, DHAI, INBS, PTHL, PAVM, LYRA, LUCY, and BTCY

Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Baird Medical Investment (BDMD), Beyond Air (XAIR), Meihua International Medical Technologies (MHUA), DIH Holding US (DHAI), Intelligent Bio Solutions (INBS), Pheton (PTHL), PAVmed (PAVM), Lyra Therapeutics (LYRA), Innovative Eyewear (LUCY), and Biotricity (BTCY). These companies are all part of the "medical equipment" industry.

Autonomix Medical vs. Its Competitors

Baird Medical Investment (NASDAQ:BDMD) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Autonomix Medical has a consensus price target of $16.50, suggesting a potential upside of 1,275.00%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Autonomix Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 32.4% of Autonomix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Baird Medical Investment has a beta of -1, indicating that its stock price is 200% less volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -2.96, indicating that its stock price is 396% less volatile than the S&P 500.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical InvestmentN/AN/AN/AN/AN/A
Autonomix MedicalN/AN/A-$11.41M-$7.47-0.16

Baird Medical Investment's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Autonomix Medical N/A -174.70%-133.35%

In the previous week, Baird Medical Investment's average media sentiment score of 0.00 equaled Autonomix Medical'saverage media sentiment score.

Company Overall Sentiment
Baird Medical Investment Neutral
Autonomix Medical Neutral

Summary

Baird Medical Investment beats Autonomix Medical on 5 of the 8 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMIX vs. The Competition

MetricAutonomix MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$6.05M$6.77B$5.44B$9.61B
Dividend YieldN/A1.35%4.61%4.14%
P/E Ratio-0.1623.6529.7624.84
Price / SalesN/A59.94449.1298.65
Price / CashN/A20.7036.4258.36
Price / Book0.365.638.185.64
Net Income-$11.41M$178.18M$3.26B$265.68M
7 Day Performance-13.67%0.14%6.88%4.95%
1 Month Performance-20.53%-5.03%1.00%0.83%
1 Year Performance-91.43%4.82%28.85%22.18%

Autonomix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMIX
Autonomix Medical
2.7947 of 5 stars
$1.20
-3.2%
$16.50
+1,275.0%
-91.0%$6.05MN/A-0.161Gap Up
BDMD
Baird Medical Investment
N/A$2.04
-2.9%
N/AN/A$13.42MN/A0.00N/A
XAIR
Beyond Air
3.9377 of 5 stars
$2.96
-7.5%
$23.67
+699.5%
-64.3%$12.79M$3.70M-0.1970Upcoming Earnings
MHUA
Meihua International Medical Technologies
0.8575 of 5 stars
$0.40
+1.9%
N/A-36.6%$12.73M$96.90M0.00620Gap Up
DHAI
DIH Holding US
0.9532 of 5 stars
$0.25
-8.4%
N/A-88.0%$11.70M$64.47M-0.82N/ANews Coverage
INBS
Intelligent Bio Solutions
0.4221 of 5 stars
$1.59
+3.9%
N/A+31.0%$10.99M$3.11M0.0010
PTHL
Pheton
N/A$1.65
-94.7%
N/AN/A$10.86M$448.20K0.0011Gap Down
High Trading Volume
PAVM
PAVmed
4.2221 of 5 stars
$0.58
+1.1%
$19.00
+3,191.2%
-42.9%$9.87M$2.99M0.8190News Coverage
Positive News
Upcoming Earnings
LYRA
Lyra Therapeutics
3.3291 of 5 stars
$7.26
-6.9%
$100.00
+1,277.4%
-56.5%$9.62M$1.19M-0.1250Upcoming Earnings
Gap Down
LUCY
Innovative Eyewear
0.0741 of 5 stars
$2.10
flat
N/A-49.7%$9.60M$1.64M-0.539Upcoming Earnings
BTCY
Biotricity
N/A$0.38
-6.3%
N/A-11.2%$9.34M$12.06M-0.3540Gap Up

Related Companies and Tools


This page (NASDAQ:AMIX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners